Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock

Recruiting now · Not applicable

Conditions studied: Septic Shock

In brief

Randomized, prospective, multicenter, open-label, controlled, parallel-group interventional trial to test the adjunctive effect of therapeutic plasma exchange in patients with early septic shock.

Key facts

Study ID
NCT05726825
Run by
Hannover Medical School
People needed
274
Starts
2025-02-19
Expected to finish
2028-04-01
Last updated by the study team
2025-03-13

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.